More Health News >>
<< Prev | Next >>

By JASON ROBERSON / The Dallas Morning News jroberson@dallasnews.com |

Testing a new drug on patients used to be done at universities, which could count on hundreds of millions of dollars a year to conduct the trials.

Monya Sigler (left) examines the skin of Nance Bastian in a clinical trial on a topical cream at Stephens & Associates. " width="175" src="http://www.wfaa.com/sharedcontent/dws/img/v3/11-03-2009.NB_03clinical1_Product.GV82NCCIG.1.jpg" height="127" alt="DAVID WOO/DMN" onclick="return clickedImage(this);" onmouseover=" this.style.cursor='hand'"> DAVID WOO/DMN Monya Sigler (left) examines the skin of Nance Bastian in a clinical trial on a topical cream at Stephens & Associates.

But as pharmaceutical companies look to cut costs and get drugs to market quicker, outsourcing to other companies is an increasingly popular option.

The change is gaining importance in North Texas, because the Dallas-Fort Worth area is becoming a hot spot for clinical trials. They used to be limited to university hospitals and biotechnology centers in the Boston area.

Text A Friend >>

<< Prev | Next >>
More Health News >>